Anaplastic Thyroid Cancer

Anaplastic Thyroid Cancer, explained simply

Everything a patient or caregiver wants to understand: what anaplastic thyroid cancer is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is anaplastic thyroid cancer?

Anaplastic thyroid cancer is a rare and aggressive cancer of the thyroid, the butterfly-shaped gland in the front of the neck that controls metabolism. Unlike the far more common and very treatable differentiated thyroid cancers (papillary and follicular), anaplastic thyroid cancer grows rapidly, often appearing as a quickly enlarging neck mass that may cause hoarseness, trouble swallowing, or difficulty breathing as it presses on the windpipe and voice box. It tends to occur in older adults and is considered a medical urgency — evaluation and treatment need to begin quickly. Importantly, anaplastic thyroid cancer does not take up radioactive iodine the way differentiated thyroid cancers do, so the iodine treatment used for those cancers does not work here; instead, treatment relies on a combination of surgery (when possible), external-beam radiation, chemotherapy, and increasingly, targeted drugs chosen based on the tumor's genetic makeup. A major advance in recent years is the discovery that a portion of these cancers carry a specific gene change (a BRAF mutation) that can be treated with targeted pills, sometimes shrinking tumors enough to allow surgery. Because care must be fast and coordinated, anaplastic thyroid cancer is best managed by an experienced multidisciplinary team, and clinical trials are an important option.

In one line: Anaplastic thyroid cancer is a rare, fast-growing thyroid cancer that requires urgent, coordinated treatment — and new targeted drugs matched to its genetics are improving outcomes for some patients.

The main types

Doctors group anaplastic thyroid cancer by where it starts and how it behaves:

TypeWhat it means, simply
Anaplastic (undifferentiated) thyroid carcinomaThe main and defining type — a fast-growing thyroid cancer whose cells have lost the features of normal thyroid tissue, which is why it does not respond to radioactive iodine.
BRAF-mutated anaplastic thyroid cancerA subset that carries a specific BRAF gene change; these can be treated with targeted pills that block that gene, sometimes shrinking the tumor enough to allow surgery.
Anaplastic transformation from differentiated cancerSometimes anaplastic cancer arises from a pre-existing, slower-growing thyroid cancer that changes into this more aggressive form over time.

Staging, in plain terms

Because anaplastic thyroid cancer is so aggressive, the staging system treats every case as stage IV by definition — there is no stage I, II, or III. What matters for planning treatment is which stage IV subgroup a patient falls into: stage IVA means the cancer is still confined within the thyroid area; stage IVB means it has grown into nearby structures in the neck or to neck lymph nodes but not to distant organs; and stage IVC means it has spread to distant parts of the body such as the lungs or bones. This grouping helps the team decide whether the goal can be aggressive treatment aimed at controlling the cancer in the neck (often surgery plus radiation, sometimes after targeted drugs shrink the tumor) or whether systemic therapy to slow widespread disease is the priority. Even though the staging sounds alarming, treatment options — especially targeted therapies for tumors with specific mutations — have been improving.

TNM — but all anaplastic thyroid cancer is classified as stage IVWhat it generally means
Stage IVAThe cancer is still contained within the thyroid; this is the most favorable category and may allow surgery combined with radiation.
Stage IVBThe cancer has grown into nearby neck structures or lymph nodes but has not spread to distant organs; treated with combinations of targeted therapy, surgery when feasible, and radiation.
Stage IVCThe cancer has spread to distant organs such as the lungs or bones; treatment focuses on systemic therapy — often targeted drugs matched to the tumor's genetics — along with radiation to control the neck.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Anaplastic Thyroid Cancer is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Targeted therapy (for specific mutations)

When the tumor carries a BRAF mutation, combination targeted pills can rapidly shrink it, sometimes making a previously inoperable cancer removable; testing the tumor's genetics early is now a key step.

External-beam radiation therapy

Intensive radiation to the neck is a central treatment to control the cancer locally and relieve or prevent pressure on the airway and swallowing; it is often combined with chemotherapy or given after surgery.

Surgery

When the cancer can be removed — sometimes only after targeted drugs shrink it — surgery to take out the thyroid and involved tissue improves the chance of controlling the disease in the neck.

Chemotherapy

Chemotherapy may be given together with radiation to make it more effective and to address cancer cells throughout the body.

Airway protection and supportive care

Because the cancer can compress the windpipe, urgent steps to protect breathing and swallowing, along with strong symptom and nutritional support, are an essential part of care.

How radiation treatment works

Radiation uses focused high-energy beams to damage the DNA inside cancer cells so they can no longer grow and divide. In anaplastic thyroid cancer, radiation plays a central role because this cancer grows quickly in the neck and threatens vital structures such as the windpipe, voice box, and swallowing muscles. Radiation is used to control the cancer locally — shrinking it, relieving or preventing pressure on the airway, and reducing the chance it regrows in the neck — and it is frequently combined with chemotherapy or given after surgery. Modern techniques such as IMRT shape a high dose tightly around the tumor while sparing the spinal cord and as much of the swallowing and breathing structures as possible. A particularly hopeful development is that for tumors with a BRAF mutation, targeted pills can shrink the cancer first, after which radiation and surgery can consolidate that response. Because timing matters in this fast-moving disease, radiation is often started promptly and coordinated closely with the rest of the team. When the focus is comfort, shorter palliative courses of radiation can quickly ease pain, pressure, and breathing or swallowing problems. Your radiation oncologist will tailor the dose and technique to the goal of care — whether aggressive control or symptom relief — and to protecting the structures of the neck.

The main ways radiation is delivered for anaplastic thyroid cancer:

Intensity-modulated radiation therapy (IMRT)

IMRT delivers a high, shaped dose to the cancer in the neck while sparing the spinal cord, swallowing structures, and airway as much as possible — important when treating a tumor close to vital structures.

Concurrent chemoradiation

Radiation combined with chemotherapy can improve local control of this fast-growing cancer and is a common approach when the goal is aggressive treatment of disease in the neck.

Radiation after targeted-drug response

When targeted pills shrink a BRAF-mutated tumor, radiation (often with surgery) is used to consolidate that response and control the cancer in the neck.

Palliative radiation

When the priority is comfort and airway protection, shorter courses of radiation can quickly relieve pressure, pain, and breathing or swallowing difficulty.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

Targeted therapy for BRAF-mutated tumors: The discovery that a portion of anaplastic thyroid cancers carry a BRAF mutation led to combination targeted pills that can dramatically shrink these tumors, sometimes making inoperable cancers removable and improving survival.[1]

BRAF-targeted therapy thyroid trials

Rapid genetic testing to guide treatment: Because anaplastic thyroid cancer moves quickly and treatment depends on the tumor's genetics, experts now recommend urgent molecular testing so targeted and immunotherapy options can be started without delay.[2]

Anaplastic thyroid cancer management guidelines

Multimodal therapy improving local control: Combining surgery, intensive radiation, and systemic therapy has improved control of the cancer in the neck and, for some patients with limited disease, longer survival than was historically expected.[3]

Multimodal anaplastic thyroid cancer studies

Common questions

Why won't radioactive iodine work for this cancer? Radioactive iodine treats the common, slower thyroid cancers because their cells absorb iodine. Anaplastic thyroid cancer cells have lost that ability, so iodine treatment does not work. Instead, treatment relies on external-beam radiation, surgery, chemotherapy, and targeted drugs.

Why is genetic testing of the tumor so important and so urgent? A portion of anaplastic thyroid cancers carry a BRAF mutation that can be treated with targeted pills, which sometimes shrink the tumor enough to allow surgery. Because the cancer grows fast, testing the tumor's genetics quickly lets the team start the most effective treatment without delay.

Should I consider a clinical trial? Yes — clinical trials are an important option in anaplastic thyroid cancer and may provide access to newer targeted and immune therapies. Ask your team whether a trial is appropriate for your situation; acting quickly is important with this diagnosis.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. BRAF-targeted therapy thyroid trials (no indexed identifier — see your care team)
  2. Anaplastic thyroid cancer management guidelines (no indexed identifier — see your care team)
  3. Multimodal anaplastic thyroid cancer studies (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides